We had previously observed that a number of NF-kB targets, identified by the IPA software in the ‘tissue remodelling’ section of the network, were up-regulated during training in healthy individuals, but failed to respond in COPD patients (Figure 4A). This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.